Price T Rowe Associates Inc Legend Biotech Corp Transaction History

Price T Rowe Associates Inc

$812 Billion
Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 6,729,779 shares of LEGN stock, worth $202 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,729,779

Previous 6,808,081 1.15%

Holding current value

$202 Million

Previous $222 Million 3.07%

% of portfolio

0.03%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$31.43 - $39.7 $2.46 Million - $3.11 Million	-78,302 Reduced 1.15%	6,729,779 $228 Million
Q4 2024 Feb 14, 2025	SELL	$32.49 - $50.28 $142 Million - $219 Million	-4,357,503 Reduced 39.03%	6,808,081 $222 Million
Q3 2024 Nov 14, 2024	SELL	$43.55 - $59.88 $14.1 Million - $19.4 Million	-323,691 Reduced 2.82%	11,165,584 $544 Million
Q2 2024 Aug 14, 2024	BUY	$39.5 - $57.22 $21.3 Million - $30.9 Million	540,155 Added 4.93%	11,489,275 $509 Million
Q1 2024 May 15, 2024	BUY	$55.06 - $69.99 $7.76 Million - $9.86 Million	140,904 Added 1.3%	10,949,120 $614 Million
Q4 2023 Feb 14, 2024	BUY	$57.25 - $69.74 $63.8 Million - $77.7 Million	1,114,848 Added 11.5%	10,808,216 $650 Million
Q3 2023 Nov 14, 2023	BUY	$63.16 - $76.5 $41.8 Million - $50.6 Million	662,044 Added 7.33%	9,693,368 $651 Million
Q2 2023 Aug 14, 2023	BUY	$46.28 - $75.01 $367 Million - $596 Million	7,939,175 Added 726.93%	9,031,324 $623 Million
Q1 2023 May 15, 2023	BUY	$43.42 - $57.37 $19 Million - $25.1 Million	437,630 Added 66.86%	1,092,149 $52.7 Million
Q4 2022 Feb 14, 2023	SELL	$38.8 - $55.46 $49,625 - $70,933	-1,279 Reduced 0.2%	654,519 $32.7 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $3.38 Million - $5.06 Million	88,643 Added 15.63%	655,798 $26.8 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $19 Million - $31.2 Million	567,155 New	567,155 $31.2 Million
Q2 2021 Aug 16, 2021	SELL	$25.8 - $41.09 $3.21 Million - $5.1 Million	-124,229 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$23.55 - $32.4 $10.7 Million - $14.8 Million	-455,548 Reduced 78.57%	124,229 $3.61 Million
Q4 2020 Feb 16, 2021	BUY	$25.8 - $32.39 $15 Million - $18.8 Million	579,777 New	579,777 $16.3 Million

Others Institutions Holding LEGN

# of Institutions

229

Shares Held

74.4M

Call Options Held

247K

Put Options Held

406K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.03B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Legend Biotech Corp Transaction History